TY - JOUR
AU - Rudan, Igor
AU - Kerr, Steven
AU - Sullivan, Christopher
AU - Jeffrey, Karen
AU - Grange, Zoe
AU - Fenton, Lynda
AU - Kurdi, Amanj
AU - Shi, Ting
AU - Cullen, Lucy
AU - Simpson, Colin R.
AU - Katikireddi, Srinivasa Vittal
AU - Ritchie, Lewis
AU - Robertson, Chris
AU - Sheikh, Aziz
PY - 2025
DA - August
TI - BNT162b2 COVID-19 vaccination uptake, safety, effectiveness, and waning in children and young people aged 5–11 years in Scotland
JO - Journal of Global Health
VL - 15
DO - https://doi.org/10.7189/jogh.15.04250
AB - Background Few large-scale population studies have examined both safety and vaccine effectiveness (VE) specifically for 5–11-year-olds during the Omicron-dominant period in a setting with low vaccine uptake. The BNT162b2 (Pfizer-BioNTech) vaccine, administered in two doses, has shown strong efficacy against symptomatic and severe COVID-19 in clinical trials involving children and young people (CYP). Accordingly, we examined the uptake, real-world safety, VE, and waning of BNT162b2 VE against symptomatic COVID-19 among children aged 5–11 years in Scotland.
PB - International Society of Global Health
UR - https://pureportal.strath.ac.uk/en/publications/bnt162b2-covid-19-vaccination-uptake-safety-effectiveness-and-wan-2
KW - Coronavirus (COVID-19)
KW - Immunisation and screening
KW - Children, young people and families
ER